Related Experiment Video
Updated: Jan 6, 2026

A Visual Assay to Monitor T6SS-mediated Bacterial Competition
Published on: March 20, 2013
Structural and functional insights into Pseudomonas aeruginosa's secretion systems 1-6: regulation, role in microbial
Tanzina Akter1,2, Paula-Maree Challita3, Abrar Maswood Haider4
1School of Optometry and Vision Science, Faculty of Medicine and Health, University of New South Wales (UNSW), Sydney, NSW, 2052, Australia. t.akter@unsw.edu.au.
Background:
Pseudomonas aeruginosa is a versatile Gram-negative pathogen that thrives in diverse environments. This pathogen causes a range of infections, including microbial keratitis (MK), a sight-threatening corneal infection. Central to its virulence are six specialized protein secretion systems (Types 1-6) that span the complex cell envelope. One-step systems (Types 1, 3, 4, 6) directly translocate effectors across both of its cell membranes, while two-step systems (Types 2, 5) first export substrates into the periplasm via the Sec or Tat pathways before outer-membrane release. These molecular machines deliver toxins, enzymes and competitive effectors that facilitate tissue damage, immune evasion, nutrient acquisition, biofilm formation and interbacterial killing. Their expression and activity are often coordinated by quorum-sensing networks (Las, Rhl, Pqs, Iqs). Although various secretion systems and their effectors have been characterized, the specific contributions of each system to corneal infection have yet to be comprehensively reviewed.
Purposes And Methods:
PubMed and Google Scholar were searched to synthesize current knowledge of the structure, regulation, and substrates of these secretion systems, to highlight their contributions to keratitis pathogenesis, and to evaluate emerging anti-virulence strategies targeting these pathways as novel therapeutics.
Results:
The T3SS system and its effectors ExoU and ExoS play dominant roles in keratitis severity while other secretion systems further enhance virulence by facilitating toxin release, biofilm development, and interbacterial competition. Regulatory interactions with quorum-sensing pathways amplify their impact during infection.
Conclusion:
Understanding the functional roles of all six secretion pathways and their regulatory mechanisms will be critical for identifying and developing novel anti-virulence therapeutics for MK.
Insights
Pseudomonas aeruginosa uses six secretion systems to cause microbial keratitis. Targeting these systems, especially the T3SS, offers a promising strategy for developing new anti-virulence therapies.
Area of Science:
- Microbiology
- Ophthalmology
- Pathogenesis
Background:
- Pseudomonas aeruginosa is a Gram-negative pathogen causing sight-threatening microbial keratitis (MK).
- Six specialized protein secretion systems (Types 1-6) are crucial for P. aeruginosa virulence, delivering toxins and facilitating immune evasion, biofilm formation, and interbacterial killing.
- These systems are regulated by quorum-sensing networks, influencing their expression and activity.
Purpose of the Study:
- To review the structure, regulation, and substrates of P. aeruginosa secretion systems.
- To elucidate the contribution of these systems to keratitis pathogenesis.
- To evaluate anti-virulence strategies targeting these pathways for novel therapeutics.
Main Methods:
- Comprehensive literature search of PubMed and Google Scholar.
- Synthesis of current knowledge on P. aeruginosa secretion systems.
- Evaluation of therapeutic strategies targeting these virulence pathways.
Main Results:
- The Type 3 Secretion System (T3SS) and its effectors (ExoU, ExoS) significantly contribute to keratitis severity.
- Other secretion systems enhance virulence through toxin release, biofilm development, and interbacterial competition.
- Quorum-sensing pathways amplify the impact of secretion systems during infection.
Conclusions:
- Understanding the roles and regulation of all six secretion pathways is vital for developing anti-virulence therapies for MK.
- Targeting these secretion systems presents a novel therapeutic avenue for combating P. aeruginosa infections.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Gram-negative Bacterial Protein Secretion Systems
Fimbriae, Pili, and Axial Filaments

